SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

WFRF:(Fristrup C)
 

Search: WFRF:(Fristrup C) > Bratlie S. O. > Intra-observer agre...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Intra-observer agreements in multidisciplinary team assessments of pancreatic cancer patients

Kirkegård, J. (author)
Al-Saiddi, M. (author)
Bratlie, S. O. (author)
show more...
Coolsen, M. (author)
de Haas, R. J. (author)
den Dulk, M. (author)
Fristrup, C. (author)
Greve, O. J. (author)
Harrison, E. (author)
Koutouzi, Giasemi, 1984 (author)
Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för radiologi,Institute of Clinical Sciences, Department of Radiology
Miclea, R. L. (author)
Mortensen, M. B. (author)
Nijkamp, M. W. (author)
Persson, J. (author)
Robertson, F. P. (author)
Slangen, J. J. G. (author)
Søreide, J. A. (author)
Wigmore, S. J. (author)
Mortensen, F. V. (author)
show less...
 (creator_code:org_t)
2021-09-07
2021
English.
In: Journal of Surgical Oncology. - : Wiley. - 0022-4790 .- 1096-9098. ; 124:8, s. 1402-1408
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background and Methods: Treatment strategies for pancreatic cancer patients are made by a multidisciplinary team (MDT) board. We aimed to assess intra-observer variance at MDT boards. Participating units staged, assessed resectability, and made treatment allocations for the same patients as they did two years earlier. We disseminated clinical information and CT images of pancreatic cancer patients judged by one MDT board to have nonmetastatic pancreatic cancer to the participating units. All units were asked to re-assess the TNM stage, resectability, and treatment allocation for each patient. To assess intra-observer variance, we computed %-agreements for each participating unit, defined as low (<50%), moderate (50%–75%), and high (>75%) agreement. Results: Eighteen patients were re-assessed by six MDT boards. The overall agreement was moderate for TNM-stage (ranging from 50%–70%) and resectability assessment (53%) but low for treatment allocation (46%). Agreement on resectability assessments was low to moderate. Findings were similar but more pronounced for treatment allocation. We observed a shift in treatment strategy towards increasing use of neoadjuvant chemotherapy, particularly in patients with borderline resectable and locally advanced tumors. Conclusions: We found substantial intra-observer agreement variations across six different MDT boards of 18 pancreatic cancer patients with two years between the first and second assessment. © 2021 Wiley Periodicals LLC

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kirurgi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Surgery (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

neoadjuvant chemotherapy
pancreatic cancer
resectability
treatment allocation
variation

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view